The meeting of the Subject Expert Committee of Central Drug Standards Control Organisation is scheduled to be held today to discuss Dr Reddy’s application seeking emergency use approval for Sputnik V vaccine.Covid-19 vaccine India update: The Subject Expert Committee (SEC) of the Central Drug Standards Control Organisation is likely to meet today to take a call on emergency use approval for the Russian Covid-19 vaccine, Sputnik V. India has so far approved two vaccines — Serum-Oxford’s Covid-19 vaccine Covishied and Bharat Biotech’s Covaxin—for emergency use against Coronavirus.
According to a report in ANI, citing officials, the meeting of the Subject Expert Committee (SEC) scheduled to be held today to discuss Dr Reddy’s application seeking emergency use approval for the Sputnik V vaccine.
Dr Reddy’s Laboratories last week approached the Drug Controller General of India (DGCI) to get emergency use authorisation for the Russia-developed corona vaccine Sputnik-V. According to Dr Reddy’s, it aims to launch Sputnik-V in March if gets the necessary regulatory clearance.
(To be updated)
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.
